Grand Angels

Grand Angels is a Michigan-based angel investment group committed to fostering economic development in the Great Lakes region by investing in early-stage companies. The group focuses on sectors such as advanced manufacturing, alternative energy, business services, consumer products, engineering design, information technology, life sciences, media, medical device technology, mobility, and professional services. Grand Angels primarily invests in companies located in Michigan and neighboring states, aiming to support business growth, job creation, and talent retention in the region.

Established in 2004, Grand Angels has grown to become one of the most active angel investor groups in Michigan, with a membership of over 50 investors. The group offers initial investments ranging from $250,000 to $1 million, providing both financial support and strategic guidance to portfolio companies. Grand Angels is a member of the Michigan Capital Network, collaborating with other regional groups to enhance the entrepreneurial ecosystem across the state.

Over the years, Grand Angels has invested in a diverse array of companies, including Ocuphire Pharma, Ambiq Micro, HistoSonics, Micro-LAM Technologies, Tetra Discovery, Reconstruct, Blue Medora, Gemphire Therapeutics, and HistoSonics. The group's investment strategy emphasizes patient exit timelines, aligning funding with the developmental needs of startups. This approach has contributed to the growth and success of numerous ventures in the Midwest, reinforcing Grand Angels' reputation as a key player in the region's investment landscape.